FETZIMA

This brand name is authorized in Canada, United Kingdom, United States

Active ingredients

The drug FETZIMA contains one active pharmaceutical ingredient (API):

1 Milnacipran UNII 371U2ZK31U - LEVOMILNACIPRAN HYDROCHLORIDE

Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the management of fibromyalgia in patients that are 18 years old or above. Read about Milnacipran

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FETZIMA Extended release capsule	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AX17	Milnacipran	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02440970, 02440989, 02440997, 02441004
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 295082, 295090
Country: US	FDA, National Drug Code	Identifier(s): 0456-2212, 0456-2220, 0456-2240, 0456-2280